'Drastic Consequences' Would Dog FDA's Plan to Register Labs as Device Makers

The suggestion to register clinical labs as medical device manufacturers and list their LDT services as products would create "drastic and adverse unintended consequences" for the labs, according to the coalition.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

After an FDA recommendation,

After an FDA recommendation, the maker of Darvocet and Darvon has pulled the painkillers off the market. The painkilling drug causes dangerous abnormal heart rhythms. Darvocet can not anymore be prescribed by a doctor in the United States of America The Food and Drug Administration recommends that anybody taking the drug ask their doctor for an option as soon as possible. The maker would rather pull the drug than risk a law suit costing them a lot of fast cash.